Identification of Isoliensinine as a Novel CCR5 Inhibitor for the Prevention of Skeletal Muscle Atrophy Through Virtual Screening and Experimental Validation. [PDF]
Qu T +5 more
europepmc +1 more source
Design, synthesis and biological evaluation of a β-galactosidase-activated glycopeptide analogue of somatostatin. [PDF]
O'Leary CJ +7 more
europepmc +1 more source
CReM-pharm: de novo 3D pharmacophore-based design with synthetic accessibility awareness. [PDF]
Denzler A +3 more
europepmc +1 more source
Molecular basis for depsipeptide HDAC inhibitor combinatorial biosynthesis. [PDF]
Passmore M +8 more
europepmc +1 more source
AI-assisted design and virtual profiling of targeted degraders for pancreatic cancer therapy via PROTAC technology. [PDF]
Du B +5 more
europepmc +1 more source
Graphene Oxide-Hydroxyapatite Nanocomposite Coatings and Extracellular Matrix Protein Interactions for Enhanced Osseointegration in Dental Implants. [PDF]
Saini RS +5 more
europepmc +1 more source
Vitamin B<sub>1</sub>-catalyzed green synthesis and antiplasmodial evaluation of 2-amino-7-hydroxy-4-aryl-4<i>H</i>-chromene-3-carbonitrile derivatives: computational insights into putative PfNDH2 targeting. [PDF]
Patil P +8 more
europepmc +1 more source
In Silico Studies of Potent Tyrosine Kinase Inhibitors: Molecular Docking and Pharmacophore Modeling Approaches. [PDF]
Mavridis E +2 more
europepmc +1 more source
Medicinal Chemistry of Small-Molecule c-Met Inhibitors: From Approved Therapies to Emerging Multitarget Anticancer Agents. [PDF]
Panda SS +7 more
europepmc +1 more source
In silico prioritization of potential matrix metalloproteinase-13 inhibitors for cartilage degeneration in knee injury-associated osteoarthritis. [PDF]
Zhang A +7 more
europepmc +1 more source

